Please login to the form below

Not currently logged in
Email:
Password:

Warner Chilcott buy P&G's pharma business

Warner Chilcott, the speciality pharmaceuticals company, is to acquire Proctor & Gamble's portfolio of branded pharmaceutical products

Warner Chilcott, the speciality pharmaceuticals company, is to acquire Proctor & Gamble's portfolio of branded pharmaceutical products.

The porfolio of products involved in the acquisition includes Asacol HD (mesalamine), Actone (risedronate sodium) and the co-promotion rights to Enablex (darifenacin), as well as Proctor & Gamble's (P&G) prescription drug product pipeline and manufacturing facilities in Puerto Rico and Germany. Of the 2,300 employees at P&G's pharmaceuticals business, the majority are expected to transfer to Warner Chilcott.

The transaction – for $3.1bn – is likely to close by the end of 2009, pending necessary regulatory approvals. 

Said Roger Boissonneault, president and chief executive officer of Warner Chilcott: "The acquisition transforms Warner Childcott into a global pharmaceutical company, expands our presence in women's healthcare, establishes us in the urology market in advance of the anticipated launch of our erectile dysfunction treatments, and adds gastroenterology therapies to our product portfolio."

P&G said that it believes Warner Chilcott will be a strong investor in P&G's pharmaceutical assets, brands and capabilities and that the move will enable them to "focus singularly on winning in consumer health care".

24th August 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Pegasus

Pegasus inspires healthy decisions through creative, inspirational and integrated communications. Working with ambitious clients, we deliver big ideas and far-reaching...

Latest intelligence

women
Advancing women in healthcare
Fostering the next generation of leaders...
The Challenges Of UX In Healthcare: Technology To Change Lives
Blue Latitude Health Director and Head of Customer Experience Elisa Del Galdo explores the latest digital healthcare trends and reveals the innovations changing the sector today....
It’s all about patient outcomes… right?
Lessons from history: a design thinking perspective...

Infographics